Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022
Thu, May 19, 2022
Wed, May 18, 2022
Tue, May 17, 2022

Christopher Raymond Maintained (ALXO) at Buy with Decreased Target to $48 on, May 19th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-48-on-may-19th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Decreased Target from $70 to $48 on, May 19th, 2022.

Christopher has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Tuesday, March 1st, 2022

Publication Contributing Sources